Pacific Biosciences (PACB) announced Monday morning that it has released a major upgrade to its PacBio RS system, including new chemistry, enhanced SMRT Cells and upgraded software.
Shares of Pacific Biosciences have been rising since the open Monday and are now up 0.76 at $5.23 on above average volume. The stock has broken out of a 2 1/2 week range and has set over a 4 1/2 month high.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.